08. Juni 2016

Epigenomics AG: Veröffentlichung gemäß § 26 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung

DGAP Stimmrechtsmitteilung: Epigenomics AG

2016-06-08 / 15:51
Veröffentlichung einer Stimmrechtsmitteilung übermittelt durch DGAP – ein Service der EQS Group AG.
Für den Inhalt der Mitteilung ist der Emittent verantwortlich.

Stimmrechtsmitteilung

1. Angaben zum Emittenten

Epigenomics AG
Geneststraße 5
10829 Berlin
Deutschland

2. Grund der Mitteilung

X	Erwerb/Veräußerung von Aktien mit Stimmrechten
	Erwerb/Veräußerung von Instrumenten
	Änderung der Gesamtzahl der Stimmrechte
X	Sonstiger Grund: underwriting position in capital increase transaction

3. Angaben zum Mitteilungspflichtigen

Name:	Registrierter Sitz und Staat:
UniCredit S.p.A.	Mailand Italien

4. Namen der Aktionäre
mit 3% oder mehr Stimmrechten, wenn abweichend von 3.

Bankhaus Neelmeyer AG

5. Datum der Schwellenberührung

02.06.2016

6. Gesamtstimmrechtsanteile

	Anteil Stimmrechte (Summe 7.a.)	Anteil Instrumente (Summe 7.b.1.+ 7.b.2.)	Summe Anteile (Summe 7.a. + 7.b.)	Gesamtzahl Stimmrechte des Emittenten
neu	6,98987 %	%	6,98987 %	20544009
letzte Mitteilung	0,23 %	%	0,23 %	/

7. Einzelheiten zu den Stimmrechtsbeständen
a. Stimmrechte (§§ 21, 22 WpHG)

ISIN	absolut		in %
	direkt (§ 21 WpHG)	zugerechnet (§ 22 WpHG)	direkt (§ 21 WpHG)	zugerechnet (§ 22 WpHG)
DE000A11QW50	0	1436000	0 %	6,98987 %
Summe	1436000		6,98987 %

b.1. Instrumente i.S.d. § 25 Abs. 1 Nr. 1 WpHG

Art des Instruments	Fälligkeit / Verfall	Ausübungszeitraum / Laufzeit	Stimmrechte absolut	Stimmrechte in %
				%
		Summe		%

b.2. Instrumente i.S.d. § 25 Abs. 1 Nr. 2 WpHG

Art des Instruments	Fälligkeit / Verfall	Ausübungszeitraum / Laufzeit	Barausgleich oder physische Abwicklung	Stimmrechte absolut	Stimmrechte in %
					%
			Summe		%

8. Informationen in Bezug auf den Mitteilungspflichtigen

	Mitteilungspflichtiger (3.) wird weder beherrscht noch beherrscht Mitteilungspflichtiger andere Unternehmen mit melderelevanten Stimmrechten des Emittenten (1.).
X	Vollständige Kette der Tochterunternehmen beginnend mit der obersten beherrschenden Person oder dem oberstem beherrschenden Unternehmen:

Unternehmen	Stimmrechte in %, wenn 3% oder höher	Instrumente in %, wenn 5% oder höher	Summe in %, wenn 5% oder höher
UniCredit S.p.A.	%	%	%
UniCredit Bank AG	%	%	%
Bankhaus Neelmeyer AG	6,98987 %	%	6,98987 %

9. Bei Vollmacht gemäß § 22 Abs. 3 WpHG
(nur möglich bei einer Zurechnung nach § 22 Abs. 1 Satz 1 Nr. 6 WpHG)

Datum der Hauptversammlung:
Gesamtstimmrechtsanteil nach der Hauptversammlung:	% (entspricht Stimmrechten)

2016-06-08 Die DGAP Distributionsservices umfassen gesetzliche Meldepflichten, Corporate News/Finanznachrichten und Pressemitteilungen.
Medienarchiv unter http://www.dgap.de

Sprache:	Deutsch
Unternehmen:	Epigenomics AG
	Geneststraße 5
	10829 Berlin
	Deutschland
Internet:	www.epigenomics.com


Ende der Mitteilung	DGAP News-Service

07. Juni 2016

Epigenomics AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

DGAP Voting Rights Announcement: Epigenomics AG

2016-06-07 / 12:06
Dissemination of a Voting Rights Announcement transmitted by DGAP – a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Notification of Major Holdings

1. Details of issuer

Epigenomics AG
Geneststraße 5
10829 Berlin
Germany

2. Reason for notification

	Acquisition/disposal of shares with voting rights
	Acquisition/disposal of instruments
	Change of breakdown of voting rights
X	Other reason: Acquisition of the majority of shares in a direct shareholder of Epigenomics AG

3. Details of person subject to the notification obligation

Name:	City and country of registered office:
Global Bio Information Technologies Partners GP Ltd.	George Town, Grand Cayman Cayman Islands

4. Names of shareholder(s)
holding directly 3% or more voting rights, if different from 3.

BioChain Institute, Inc.

5. Date on which threshold was crossed or reached

28 March 2016

6. Total positions

	% of voting rights attached to shares (total of 7.a.)	% of voting rights through instruments (total of 7.b.1 + 7.b.2)	total of both in % (7.a. + 7.b.)	total number of voting rights of issuer
Resulting situation	5.97 %	%	5.97 %	18700159
Previous notification	%	%	%	/

7. Notified details of the resulting situation
a. Voting rights attached to shares (Sec.s 21, 22 WpHG)

ISIN	absolute		in %
	direct (Sec. 21 WpHG)	indirect (Sec. 22 WpHG)	direct (Sec. 21 WpHG)	indirect (Sec. 22 WpHG)
DE000A11QW50		1115685	%	5.97 %
Total	1115685		5.97 %

b.1. Instruments according to Sec. 25 para. 1 No. 1 WpHG

Type of instrument	Expiration or maturity date	Exercise or conversion period	Voting rights absolute	Voting rights in %
				%
		Total		%

b.2. Instruments according to Sec. 25 para. 1 No. 2 WpHG

Type of instrument	Expiration or maturity date	Exercise or conversion period	Cash or physical settlement	Voting rights absolute	Voting rights in %
					%
			Total		%

8. Information in relation to the person subject to the notification obligation

	Person subject to the notification obligation is not controlled and does itself not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer (1.).
X	Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity:

Name	% of voting rights (if at least held 3% or more)	% of voting rights through instruments (if at least held 5% or more)	Total of both (if at least held 5% or more)
Global Bio Information Technologies Partners GP Ltd.	%	%	%
Global Bio and Information Technologies Partners L.P.	%	%	%
Kevron Holdings, Ltd.	%	%	%
Biochain (BVI) Holdings, Ltd.	%	%	%
BioChain Institute, Inc.	5.97 %	%	5.97 %

9. In case of proxy voting according to Sec. 22 para. 3 WpHG

Date of general meeting:
Holding position after general meeting:	% (equals voting rights)

2016-06-07 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de

Language:	English
Company:	Epigenomics AG
	Geneststraße 5
	10829 Berlin
	Germany
Internet:	www.epigenomics.com


End of News	DGAP News Service

07. Juni 2016

Epigenomics AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

DGAP Voting Rights Announcement: Epigenomics AG

2016-06-07 / 11:57
Dissemination of a Voting Rights Announcement transmitted by DGAP – a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Notification of Major Holdings

1. Details of issuer

Epigenomics AG
Geneststraße 5
10829 Berlin
Germany

2. Reason for notification

	Acquisition/disposal of shares with voting rights
	Acquisition/disposal of instruments
	Change of breakdown of voting rights
X	Other reason: Acquisition of the majority of shares in a direct shareholder of Epigenomics AG

3. Details of person subject to the notification obligation

Name:	City and country of registered office:
Global Bio and Information Technologies Partners L.P.	George Town, Grand Cayman Cayman Islands

4. Names of shareholder(s)
holding directly 3% or more voting rights, if different from 3.

BioChain Institute, Inc.

5. Date on which threshold was crossed or reached

28 March 2016

6. Total positions

	% of voting rights attached to shares (total of 7.a.)	% of voting rights through instruments (total of 7.b.1 + 7.b.2)	total of both in % (7.a. + 7.b.)	total number of voting rights of issuer
Resulting situation	5.97 %	%	5.97 %	18700159
Previous notification	%	%	%	/

7. Notified details of the resulting situation
a. Voting rights attached to shares (Sec.s 21, 22 WpHG)

ISIN	absolute		in %
	direct (Sec. 21 WpHG)	indirect (Sec. 22 WpHG)	direct (Sec. 21 WpHG)	indirect (Sec. 22 WpHG)
DE000A11QW50		1115685	%	5.97 %
Total	1115685		5.97 %

b.1. Instruments according to Sec. 25 para. 1 No. 1 WpHG

Type of instrument	Expiration or maturity date	Exercise or conversion period	Voting rights absolute	Voting rights in %
				%
		Total		%

b.2. Instruments according to Sec. 25 para. 1 No. 2 WpHG

Type of instrument	Expiration or maturity date	Exercise or conversion period	Cash or physical settlement	Voting rights absolute	Voting rights in %
					%
			Total		%

8. Information in relation to the person subject to the notification obligation

	Person subject to the notification obligation is not controlled and does itself not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer (1.).
X	Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity:

Name	% of voting rights (if at least held 3% or more)	% of voting rights through instruments (if at least held 5% or more)	Total of both (if at least held 5% or more)
Global Bio Information Technologies Partners GP Ltd.	%	%	%
Global Bio and Information Technologies Partners L.P.	%	%	%
Kevron Holdings, Ltd.	%	%	%
Biochain (BVI) Holdings, Ltd.	%	%	%
BioChain Institute, Inc.	5.97 %	%	5.97 %

9. In case of proxy voting according to Sec. 22 para. 3 WpHG

Date of general meeting:
Holding position after general meeting:	% (equals voting rights)

2016-06-07 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de

Language:	English
Company:	Epigenomics AG
	Geneststraße 5
	10829 Berlin
	Germany
Internet:	www.epigenomics.com


End of News	DGAP News Service

07. Juni 2016

Epigenomics AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

DGAP Voting Rights Announcement: Epigenomics AG

2016-06-07 / 11:51
Dissemination of a Voting Rights Announcement transmitted by DGAP – a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Notification of Major Holdings

1. Details of issuer

Epigenomics AG
Geneststraße 5
10829 Berlin
Germany

2. Reason for notification

	Acquisition/disposal of shares with voting rights
	Acquisition/disposal of instruments
	Change of breakdown of voting rights
X	Other reason: Acquisition of the majority of shares in a direct shareholder of Epigenomics AG

3. Details of person subject to the notification obligation

Name:	City and country of registered office:
Kevron Holdings, Ltd.	George Town, Grand Cayman Cayman Islands

4. Names of shareholder(s)
holding directly 3% or more voting rights, if different from 3.

BioChain Institute, Inc.

5. Date on which threshold was crossed or reached

28 March 2016

6. Total positions

	% of voting rights attached to shares (total of 7.a.)	% of voting rights through instruments (total of 7.b.1 + 7.b.2)	total of both in % (7.a. + 7.b.)	total number of voting rights of issuer
Resulting situation	5.97 %	%	5.97 %	18700159
Previous notification	%	%	%	/

7. Notified details of the resulting situation
a. Voting rights attached to shares (Sec.s 21, 22 WpHG)

ISIN	absolute		in %
	direct (Sec. 21 WpHG)	indirect (Sec. 22 WpHG)	direct (Sec. 21 WpHG)	indirect (Sec. 22 WpHG)
DE000A11QW50		1115685	%	5.97 %
Total	1115685		5.97 %

b.1. Instruments according to Sec. 25 para. 1 No. 1 WpHG

Type of instrument	Expiration or maturity date	Exercise or conversion period	Voting rights absolute	Voting rights in %
				%
		Total		%

b.2. Instruments according to Sec. 25 para. 1 No. 2 WpHG

Type of instrument	Expiration or maturity date	Exercise or conversion period	Cash or physical settlement	Voting rights absolute	Voting rights in %
					%
			Total		%

8. Information in relation to the person subject to the notification obligation

	Person subject to the notification obligation is not controlled and does itself not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer (1.).
X	Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity:

Name	% of voting rights (if at least held 3% or more)	% of voting rights through instruments (if at least held 5% or more)	Total of both (if at least held 5% or more)
Global Bio Information Technologies Partners GP Ltd.	%	%	%
Global Bio and Information Technologies Partners L.P.	%	%	%
Kevron Holdings, Ltd.	%	%	%
Biochain (BVI) Holdings, Ltd.	%	%	%
BioChain Institute, Inc.	5.97 %	%	5.97 %

9. In case of proxy voting according to Sec. 22 para. 3 WpHG

Date of general meeting:
Holding position after general meeting:	% (equals voting rights)

2016-06-07 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de

Language:	English
Company:	Epigenomics AG
	Geneststraße 5
	10829 Berlin
	Germany
Internet:	www.epigenomics.com


End of News	DGAP News Service

07. Juni 2016

Epigenomics AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

DGAP Voting Rights Announcement: Epigenomics AG

2016-06-07 / 10:39
Dissemination of a Voting Rights Announcement transmitted by DGAP – a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Notification of Major Holdings

1. Details of issuer

Epigenomics AG
Geneststraße 5
10829 Berlin
Germany

2. Reason for notification

	Acquisition/disposal of shares with voting rights
	Acquisition/disposal of instruments
	Change of breakdown of voting rights
X	Other reason: Acquisition of the majority of shares in a direct shareholder of Epigenomics AG

3. Details of person subject to the notification obligation

Name:	City and country of registered office:
BioChain (BVI) Holding, Ltd.	Road Town, Tortola British Virgin Islands

4. Names of shareholder(s)
holding directly 3% or more voting rights, if different from 3.

BioChain Institute, Inc.

5. Date on which threshold was crossed or reached

28 March 2016

6. Total positions

	% of voting rights attached to shares (total of 7.a.)	% of voting rights through instruments (total of 7.b.1 + 7.b.2)	total of both in % (7.a. + 7.b.)	total number of voting rights of issuer
Resulting situation	5.97 %	0 %	5.97 %	18700159
Previous notification	%	%	%	/

7. Notified details of the resulting situation
a. Voting rights attached to shares (Sec.s 21, 22 WpHG)

ISIN	absolute		in %
	direct (Sec. 21 WpHG)	indirect (Sec. 22 WpHG)	direct (Sec. 21 WpHG)	indirect (Sec. 22 WpHG)
DE000A11QW50	0	1115685	0 %	5.97 %
Total	1115685		5.97 %

b.1. Instruments according to Sec. 25 para. 1 No. 1 WpHG

Type of instrument	Expiration or maturity date	Exercise or conversion period	Voting rights absolute	Voting rights in %
				%
		Total		%

b.2. Instruments according to Sec. 25 para. 1 No. 2 WpHG

Type of instrument	Expiration or maturity date	Exercise or conversion period	Cash or physical settlement	Voting rights absolute	Voting rights in %
					%
			Total		%

8. Information in relation to the person subject to the notification obligation

	Person subject to the notification obligation is not controlled and does itself not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer (1.).
X	Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity:

Name	% of voting rights (if at least held 3% or more)	% of voting rights through instruments (if at least held 5% or more)	Total of both (if at least held 5% or more)
Global Bio Information Technologies Partners GP Ltd.	%	%	%
Global Bio and Information Technologies Partners L.P.	%	%	%
Kevron Holdings, Ltd.	%	%	%
Biochain (BVI) Holdings, Ltd.	%	%	%
BioChain Institute, Inc.	5.97 %	%	5.97 %

9. In case of proxy voting according to Sec. 22 para. 3 WpHG

Date of general meeting:
Holding position after general meeting:	% (equals voting rights)

2016-06-07 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de

Language:	English
Company:	Epigenomics AG
	Geneststraße 5
	10829 Berlin
	Germany
Internet:	www.epigenomics.com


End of News	DGAP News Service

07. Juni 2016

Epigenomics AG: Veröffentlichung gemäß § 26 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung

DGAP Stimmrechtsmitteilung: Epigenomics AG

2016-06-07 / 12:06
Veröffentlichung einer Stimmrechtsmitteilung übermittelt durch DGAP – ein Service der EQS Group AG.
Für den Inhalt der Mitteilung ist der Emittent verantwortlich.

Stimmrechtsmitteilung

1. Angaben zum Emittenten

Epigenomics AG
Geneststraße 5
10829 Berlin
Deutschland

2. Grund der Mitteilung

	Erwerb/Veräußerung von Aktien mit Stimmrechten
	Erwerb/Veräußerung von Instrumenten
	Änderung der Gesamtzahl der Stimmrechte
X	Sonstiger Grund: Erwerb der Anteilsmehrheit an einem Aktionär der Epigenomics AG

3. Angaben zum Mitteilungspflichtigen

Name:	Registrierter Sitz und Staat:
Global Bio Information Technologies Partners GP Ltd.	George Town, Grand Cayman Kaimaninseln

4. Namen der Aktionäre
mit 3% oder mehr Stimmrechten, wenn abweichend von 3.

BioChain Institute, Inc.

5. Datum der Schwellenberührung

28.03.2016

6. Gesamtstimmrechtsanteile

	Anteil Stimmrechte (Summe 7.a.)	Anteil Instrumente (Summe 7.b.1.+ 7.b.2.)	Summe Anteile (Summe 7.a. + 7.b.)	Gesamtzahl Stimmrechte des Emittenten
neu	5,97 %	%	5,97 %	18700159
letzte Mitteilung	%	%	%	/

7. Einzelheiten zu den Stimmrechtsbeständen
a. Stimmrechte (§§ 21, 22 WpHG)

ISIN	absolut		in %
	direkt (§ 21 WpHG)	zugerechnet (§ 22 WpHG)	direkt (§ 21 WpHG)	zugerechnet (§ 22 WpHG)
DE000A11QW50		1115685	%	5,97 %
Summe	1115685		5,97 %

b.1. Instrumente i.S.d. § 25 Abs. 1 Nr. 1 WpHG

Art des Instruments	Fälligkeit / Verfall	Ausübungszeitraum / Laufzeit	Stimmrechte absolut	Stimmrechte in %
				%
		Summe		%

b.2. Instrumente i.S.d. § 25 Abs. 1 Nr. 2 WpHG

Art des Instruments	Fälligkeit / Verfall	Ausübungszeitraum / Laufzeit	Barausgleich oder physische Abwicklung	Stimmrechte absolut	Stimmrechte in %
					%
			Summe		%

8. Informationen in Bezug auf den Mitteilungspflichtigen

	Mitteilungspflichtiger (3.) wird weder beherrscht noch beherrscht Mitteilungspflichtiger andere Unternehmen mit melderelevanten Stimmrechten des Emittenten (1.).
X	Vollständige Kette der Tochterunternehmen beginnend mit der obersten beherrschenden Person oder dem oberstem beherrschenden Unternehmen:

Unternehmen	Stimmrechte in %, wenn 3% oder höher	Instrumente in %, wenn 5% oder höher	Summe in %, wenn 5% oder höher
Global Bio Information Technologies Partners GP Ltd.	%	%	%
Global Bio and Information Technologies Partners L.P.	%	%	%
Kevron Holdings, Ltd.	%	%	%
Biochain (BVI) Holdings, Ltd.	%	%	%
BioChain Institute, Inc.	5,97 %	%	5,97 %

9. Bei Vollmacht gemäß § 22 Abs. 3 WpHG
(nur möglich bei einer Zurechnung nach § 22 Abs. 1 Satz 1 Nr. 6 WpHG)

Datum der Hauptversammlung:
Gesamtstimmrechtsanteil nach der Hauptversammlung:	% (entspricht Stimmrechten)

2016-06-07 Die DGAP Distributionsservices umfassen gesetzliche Meldepflichten, Corporate News/Finanznachrichten und Pressemitteilungen.
Medienarchiv unter http://www.dgap.de

Sprache:	Deutsch
Unternehmen:	Epigenomics AG
	Geneststraße 5
	10829 Berlin
	Deutschland
Internet:	www.epigenomics.com


Ende der Mitteilung	DGAP News-Service

News & Investoren

Archive

Epigenomics AG: Veröffentlichung gemäß § 26 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung

Epigenomics AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Epigenomics AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Epigenomics AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Epigenomics AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Epigenomics AG: Veröffentlichung gemäß § 26 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung

Archiv

News-Kategorien

Medienkontakt